Literature DB >> 23858507

Can clinical and MRI findings predict the prognosis of variant and classical type of posterior reversible encephalopathy syndrome (PRES)?

Seong-Nam Moon1, Se Jeong Jeon, See Sung Choi, Chang June Song, Gyung Ho Chung, In Kyu Yu, Dea Ho Kim.   

Abstract

BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) is characterized by clinical symptoms that are associated with bilateral and symmetric vasogenic edema in the parietal and occipital lobes. However, this is rarely present with predominant involvement of the brain stem and cerebellum (variant).
PURPOSE: To evaluate which clinical or magnetic resonance imaging (MRI) findings can help to predict the prognosis of variant and classical type of PRES and whether or not there is difference between two types of PRES.
MATERIAL AND METHODS: We retrospectively evaluated MRI and clinical findings from 49 patients with PRES. These patients were divided into two groups. In group I, patients had atypical distribution of lesions. In group II, patients had typical distribution of lesions. Follow-up MRI was performed on 26 patients. We assessed the MRI features, clinical data, and the patients' outcomes.
RESULTS: The mean blood pressure (BP) was significantly higher in group I (195.52/121.09 mmHg and 156.78/99.53 mmHg for groups I and II, respectively). The other factors assessed were not significantly different between the two groups. Lesions in 24 of 26 patients reversed upon follow-up. Sequelae were observed in 11 patients (group I, 7; group II, 4). However, there were no significant differences between the two groups. Except for those patients who died, seven of the nine patients with sequelae upon follow-up imaging had hemorrhage or irreversibility of lesions.
CONCLUSION: Even though BP influences the involvement of the brain stem, involvement of the brain stem is not influential on the prognosis. It seems that the influential factor to prognosis is the reversibility of lesions and hemorrhage.

Entities:  

Keywords:  Posterior reversible encephalopathy syndrome (PRES); magnetic resonance image (MRI); prognosis; variant type

Mesh:

Year:  2013        PMID: 23858507     DOI: 10.1177/0284185113491252

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  17 in total

Review 1.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

2.  How I treat and manage strokes in sickle cell disease.

Authors:  Adetola A Kassim; Najibah A Galadanci; Sumit Pruthi; Michael R DeBaun
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

3.  Posterior Reversible Encephalopathy Syndrome in Two Omani Children with Underlying Renal Diseases.

Authors:  Mohamed A El-Naggari; Dana Al-Nabhani; Ibtisam El-Nour; Alaa El-Manzalawy; Anas-Alwogud A Abdelmogheth
Journal:  Sultan Qaboos Univ Med J       Date:  2015-08-24

4.  Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study.

Authors:  Eberhard Siebert; G Bohner; T Liebig; M Endres; T G Liman
Journal:  J Neurol       Date:  2016-11-04       Impact factor: 4.849

5.  Posterior reversible encephalopathy syndrome as a complication of pre-eclampsia in the early postpartum period.

Authors:  Julie Verhaegen; Frederik Peeters; Patrick Debois; Yves Jacquemyn
Journal:  BMJ Case Rep       Date:  2019-07-16

6.  Posterior Reversible Encephalopathy in Sepsis-Associated Encephalopathy: Experience from a Single Center.

Authors:  Günseli Orhun; Serra Sencer; Erdem Tüzün; Nerses Bebek; Perihan Ergin Özcan; Mehmet Barburoğlu; Mehmet Güven Günver; Figen Esen
Journal:  Neurocrit Care       Date:  2022-02-08       Impact factor: 3.532

7.  Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome: Implications of Elevated Protein and Pleocytosis.

Authors:  Colin A Ellis; Andrew C McClelland; Suyash Mohan; Emory Kuo; Scott E Kasner; Cen Zhang; Pouya Khankhanian; Ramani Balu
Journal:  Neurohospitalist       Date:  2018-09-27

8.  Clinical Correlates of Periodic Discharges and Nonconvulsive Seizures in Posterior Reversible Encephalopathy Syndrome (PRES).

Authors:  Laure Bastide; Benjamin Legros; Nishi Rampal; Emily J Gilmore; Lawrence J Hirsch; Nicolas Gaspard
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

9.  Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis.

Authors:  Zheng Chen; Gang Zhang; Alexander Lerner; An-Hui Wang; Bo Gao; Jie Liu
Journal:  Quant Imaging Med Surg       Date:  2018-05

10.  Posterior Reversible Encephalopathy Syndrome: Incidence and Clinical Characteristics in Children With Cancer.

Authors:  Katherine R Sommers; Jodi Skiles; Brian Leland; Courtney M Rowan
Journal:  J Pediatr Hematol Oncol       Date:  2022-03-01       Impact factor: 1.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.